# Progesterone Augmentation of Nicotine Replacement Therapy Study

> **NCT02685072** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 64 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Progesterone (200 mgs BID)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02685072
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-07
- **Primary completion:** 2017-12-18
- **Final completion:** 2018-03-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02685072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02685072, "Progesterone Augmentation of Nicotine Replacement Therapy Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02685072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*